Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 87

1.

Obesity in psoriatic arthritis: Comparative prevalence and associated factors.

Queiro R, Lorenzo A, Tejón P, Coto P, Pardo E.

Medicine (Baltimore). 2019 Jul;98(28):e16400. doi: 10.1097/MD.0000000000016400.

2.

NFKBIZ and CW6 in Adalimumab Response Among Psoriasis Patients: Genetic Association and Alternative Transcript Analysis.

Coto-Segura P, González-Lara L, Batalla A, Eiris N, Queiro R, Coto E.

Mol Diagn Ther. 2019 Jul 2. doi: 10.1007/s40291-019-00409-x. [Epub ahead of print]

PMID:
31267486
3.

Hypertension is associated with increased age at the onset of psoriasis and a higher body mass index in psoriatic disease.

Queiro R, Lorenzo A, Tejón P, Pardo E, Coto P.

Clin Rheumatol. 2019 Mar 28. doi: 10.1007/s10067-019-04519-z. [Epub ahead of print]

PMID:
30924009
4.

Very Low Disease Activity, DAPSA Remission, and Impact of Disease in a Spanish Population with Psoriatic Arthritis.

Queiro R, Cañete JD, Montilla C, Abad MA, Montoro M, Gómez S, Cábez A; MAAPS Study Group.

J Rheumatol. 2019 Jul;46(7):710-715. doi: 10.3899/jrheum.180460. Epub 2019 Feb 1.

PMID:
30709957
5.

Genetic variation at the glycosaminoglycan metabolism pathway contributes to the risk of psoriatic arthritis but not psoriasis.

Aterido A, Cañete JD, Tornero J, Ferrándiz C, Pinto JA, Gratacós J, Queiró R, Montilla C, Torre-Alonso JC, Pérez-Venegas JJ, Fernández Nebro A, Muñoz-Fernández S, González CM, Roig D, Zarco P, Erra A, Rodríguez J, Castañeda S, Rubio E, Salvador G, Díaz-Torné C, Blanco R, Willisch Domínguez A, Mosquera JA, Vela P, Sánchez-Fernández SA, Corominas H, Ramírez J, de la Cueva P, Fonseca E, Fernández E, Puig L, Dauden E, Sánchez-Carazo JL, López-Estebaranz JL, Moreno D, Vanaclocha F, Herrera E, Blanco F, Fernández-Gutiérrez B, González A, Pérez-García C, Alperi-López M, Olivé Marques A, Martínez-Taboada V, González-Álvaro I, Sanmartí R, Tomás Roura C, García-Montero AC, Bonàs-Guarch S, Mercader JM, Torrents D, Codó L, Gelpí JL, López-Corbeto M, Pluma A, López-Lasanta M, Tortosa R, Palau N, Absher D, Myers R, Marsal S, Julià A.

Ann Rheum Dis. 2019 Mar;78(3). pii: e214158. doi: 10.1136/annrheumdis-2018-214158. Epub 2018 Dec 14.

PMID:
30552173
6.

Spanish Registry of Recent-onset Psoriatic Arthritis (REAPSER study): Aims and methodology.

Queiro R, Laiz A, Seoane-Mato D, Galindez Agirregoikoa E, Montilla C, Park HS, Bethencourt Baute JJ, Bustabad S, Pinto Tasende JA, Tejón P, Joven Ibáñez B, Ramírez J, Cuervo A, Cañete JD, Trenor Larraz P, Ordás C, Alonso S, García-Fernández E, Toniolo E, Moreno Ramos MJ, Beteta MD, Lojo Oliveira L, Navío Marco T, Cebrián L, Barbazán C, Maceiras F, Rodriguez-Moreno J, Steiner M, Muñoz-Fernández S, Nóvoa Medina FJ, León M, Rubio E, Medina Luezas J, Sánchez-González MD, Arévalo M, Gratacós J, Senabre JM, Rosas JC, Santos Soler G, Nieto-González JC, González C, López Robles A, Álvarez Castro C, Ruiz Montesino MD, Torrente-Segarra V, Fernández-Carballido C, Martínez-Vidal MP, Jovani V, Urruticoechea-Arana A, Cabello Fernández Y, Toledo MD, Almodóvar R, Belmonte-Serrano MÁ, Notario Ferreira I, Raya Álvarez E; Grupo de Trabajo del Proyecto REAPSER.

Reumatol Clin. 2018 Dec 3. pii: S1699-258X(18)30222-5. doi: 10.1016/j.reuma.2018.09.008. [Epub ahead of print] English, Spanish.

7.

Polyarticular evolution and late-onset psoriasis may be associated with cardiovascular disease in psoriatic arthritis.

Queiro R, Lorenzo A, Tejón P, Pardo E, Coto P, Ballina J.

Int J Rheum Dis. 2019 Feb;22(2):269-274. doi: 10.1111/1756-185X.13421. Epub 2018 Nov 5.

PMID:
30398011
8.

Remission and stringent treatment goals in psoriatic arthritis: Doctors' opinion is not enough.

Queiro R.

Joint Bone Spine. 2019 Mar;86(2):269-270. doi: 10.1016/j.jbspin.2018.06.003. Epub 2018 Jul 3. No abstract available.

PMID:
30362458
9.

Quality Standard for the Management of Patients with Psoriatic Arthritis: QUANTUM Project.

Sanz Sanz J, Beltrán E, Díaz-Miguel Pérez MC, Fernández-Carballido C, Galíndez E, García Porrua C, Gratacós J, Medina J, Queiro R, Ramírez J, Reina D, Rodríguez Lozano C, Rodríguez Martínez FJ, Rubio E, Veroz R.

Reumatol Clin. 2018 Jul 24. pii: S1699-258X(18)30129-3. doi: 10.1016/j.reuma.2018.06.011. [Epub ahead of print] English, Spanish.

10.

Ustekinumab in psoriatic arthritis: need for studies from real-world evidence.

Queiro R, Coto-Segura P.

Expert Opin Biol Ther. 2018 Sep;18(9):931-935. doi: 10.1080/14712598.2018.1504919. Epub 2018 Jul 31.

PMID:
30044656
11.

Performance of Two Screening Questionnaires for Inflammatory Arthritis in Patients with Inflammatory Bowel Disease.

Queiro R, Rodríguez-Caminero S, Riestra S, de Francisco R, Pérez-Martínez I, Ballina J.

Biomed Res Int. 2018 May 8;2018:8618703. doi: 10.1155/2018/8618703. eCollection 2018.

12.

Patient-reported outcomes in European spondyloarthritis patients: a systematic review of the literature.

Torre-Alonso JC, Queiro R, Comellas M, Lizán L, Blanch C.

Patient Prefer Adherence. 2018 May 8;12:733-747. doi: 10.2147/PPA.S162420. eCollection 2018. Review.

13.

Minimal Disease Activity and Patient-Acceptable Symptom State in Psoriatic Arthritis: A Real-World Evidence Study With Ustekinumab.

Queiro R, Brandy A, Rosado MC, Lorenzo A, Coto P, Carriles C, Alperi M, Ballina J.

J Clin Rheumatol. 2018 Oct;24(7):381-384. doi: 10.1097/RHU.0000000000000751.

PMID:
29509560
14.

Current Status of Multidisciplinary Care in Psoriatic Arthritis in Spain: NEXUS 2.0 Project.

Queiro R, Coto P, Joven B, Rivera R, Navío Marco T, de la Cueva P, Alvarez Vega JL, Narváez Moreno B, Rodriguez Martínez FJ, Pardo Sánchez J, Feced Olmos C, Pujol C, Rodríguez J, Notario J, Pujol Busquets M, García Font M, Galindez E, Pérez Barrio S, Urruticoechea-Arana A, Hergueta M, López Montilla MD, Vélez García-Nieto A, Maceiras F, Rodríguez Pazos L, Rubio Romero E, Rodríguez Fernandez Freire L, Luelmo J, Gratacós J.

Reumatol Clin. 2018 Feb 26. pii: S1699-258X(18)30030-5. doi: 10.1016/j.reuma.2018.01.010. [Epub ahead of print] English, Spanish.

15.

Prevalence and type II diabetes-associated factors in psoriatic arthritis.

Queiro R, Lorenzo A, Pardo E, Brandy A, Coto P, Ballina J.

Clin Rheumatol. 2018 Apr;37(4):1059-1064. doi: 10.1007/s10067-018-4042-1. Epub 2018 Feb 22.

PMID:
29470738
16.

Pyle's Disease: A Human Model of Differentiated Cortical and Trabecular Homeostasis.

Arboleya L, Queiro R, Alperi M, Lorenzo JA, Ballina J.

Reumatol Clin. 2018 Feb 17. pii: S1699-258X(18)30022-6. doi: 10.1016/j.reuma.2018.01.002. [Epub ahead of print] English, Spanish.

17.

Standards of care and quality indicators for multidisciplinary care models for psoriatic arthritis in Spain.

Gratacós J, Luelmo J, Rodríguez J, Notario J, Marco TN, de la Cueva P, Busquets MP, Font MG, Joven B, Rivera R, Vega JLA, Álvarez AJC, Parera RS, Carrascosa JCR, Martínez FJR, Sánchez JP, Olmos CF, Pujol C, Galindez E, Barrio SP, Arana AU, Hergueta M, Coto P, Queiro R.

Rheumatol Int. 2018 Jun;38(6):1115-1124. doi: 10.1007/s00296-018-3986-4. Epub 2018 Feb 7.

PMID:
29417210
18.

Impact of cardiovascular risk factors on the achievement of therapeutic goals in psoriatic arthritis: is there any association?

Queiro R, Cañete JD.

Clin Rheumatol. 2018 Mar;37(3):661-666. doi: 10.1007/s10067-018-4004-7. Epub 2018 Jan 29.

PMID:
29380165
19.

Recommendations of the Spanish Society of Rheumatology on treatment and use of systemic biological and non-biological therapies in psoriatic arthritis.

Torre Alonso JC, Díaz Del Campo Fontecha P, Almodóvar R, Cañete JD, Montilla Morales C, Moreno M, Plasencia-Rodríguez C, Ramírez García J, Queiro R.

Reumatol Clin. 2018 Sep - Oct;14(5):254-268. doi: 10.1016/j.reuma.2017.08.007. Epub 2017 Oct 28. English, Spanish.

20.

Recommendations for the use of methotrexate in psoriatic arthritis.

Cañete JD, Ariza-Ariza R, Bustabad S, Delgado C, Fernández-Carballido C, García Llorente JF, Loza E, Montilla C, Naranjo A, Pinto JA, Queiro R, Ramírez J, Tornero-Molina J.

Reumatol Clin. 2018 Jul - Aug;14(4):183-190. doi: 10.1016/j.reuma.2017.08.011. Epub 2017 Oct 17. English, Spanish.

21.

Recommendations for the management of comorbidity in hidradenitis suppurativa.

Dauden E, Lazaro P, Aguilar MD, Blasco AJ, Suarez C, Marin I, Queiro R, Bassas-Vila J, Martorell A, García-Campayo J.

J Eur Acad Dermatol Venereol. 2018 Jan;32(1):129-144. doi: 10.1111/jdv.14517. Epub 2017 Sep 12. Review.

PMID:
28796920
22.

Minimal disease activity and impact of disease in psoriatic arthritis: a Spanish cross-sectional multicenter study.

Queiro R, Cañete JD, Montilla C, Abad M, Montoro M, Gómez S, Cábez A; MAAPS study group.

Arthritis Res Ther. 2017 Mar 29;19(1):72. doi: 10.1186/s13075-017-1277-1.

23.

NFKBIZ in Psoriasis: Assessing the association with gene polymorphisms and report of a new transcript variant.

Coto-Segura P, Gonzalez-Lara L, Gómez J, Eiris N, Batalla A, Gómez C, Requena S, Queiro R, Alonso B, Iglesias S, Coto E.

Hum Immunol. 2017 May - Jun;78(5-6):435-440. doi: 10.1016/j.humimm.2017.02.008. Epub 2017 Mar 1.

PMID:
28259733
24.

Multidisciplinary care for psoriatic disease: Where we are and where we need to go.

Queiro R, Coto P.

Rheumatology (Oxford). 2017 Nov 1;56(11):1829-1831. doi: 10.1093/rheumatology/kew485. No abstract available.

PMID:
28053273
25.

A Single Nucleotide Polymorphism in the Il17ra Promoter Is Associated with Functional Severity of Ankylosing Spondylitis.

Vidal-Castiñeira JR, López-Vázquez A, Diaz-Peña R, Diaz-Bulnes P, Martinez-Camblor P, Coto E, Coto-Segura P, Bruges-Armas J, Pinto JA, Blanco FJ, Sánchez A, Mulero J, Queiro R, Lopez-Larrea C.

PLoS One. 2016 Jul 14;11(7):e0158905. doi: 10.1371/journal.pone.0158905. eCollection 2016.

26.

Association of IL1Β (-511 A/C) and IL6 (-174 G > C) polymorphisms with higher disease activity and clinical pattern of psoriatic arthritis.

Cubino N, Montilla C, Usategui-Martín R, Cieza-Borrela C, Carranco T, Calero-Paniagua I, Quesada A, Cañete JD, Queiro R, Sánchez MD, Hidalgo C, Martínez O, Del Pino-Montes J, Díaz-Álvarez A, González-Sarmiento R.

Clin Rheumatol. 2016 Jul;35(7):1789-94. doi: 10.1007/s10067-016-3301-2. Epub 2016 May 17.

PMID:
27188858
27.

Multidisciplinary Care Models for Patients With Psoriatic Arthritis.

Queiro R, Coto P, Rodríguez J, Notario J, Navío Marco T, de la Cueva P, Pujol Busquets M, García Font M, Joven B, Rivera R, Alvarez Vega JL, Chaves Álvarez AJ, Sánchez Parera R, Ruiz Carrascosa JC, Rodríguez Martínez FJ, Pardo Sánchez J, Feced Olmos C, Pujol C, Galindez E, Pérez Barrio S, Urruticoechea Arana A, Hergueta M, Luelmo J, Gratacós J.

Reumatol Clin. 2017 Mar - Apr;13(2):85-90. doi: 10.1016/j.reuma.2016.03.005. Epub 2016 Apr 8. English, Spanish.

28.

Common and rare CARD14 gene variants affect the antitumour necrosis factor response among patients with psoriasis.

Coto-Segura P, González-Fernández D, Batalla A, Gómez J, González-Lara L, Queiro R, Alonso B, Iglesias S, Coto E.

Br J Dermatol. 2016 Jul;175(1):134-41. doi: 10.1111/bjd.14461. Epub 2016 Apr 25.

PMID:
26854129
29.

A polyarticular onset and diabetes could be the main predictors of cardiovascular events in psoriatic arthritis.

Tejón P, Morante I, Cabezas I, Sarasqueta C, Coto P, Queiro R.

Clin Exp Rheumatol. 2016 Mar-Apr;34(2):276-81. Epub 2016 Feb 2.

PMID:
26841682
30.

Age at disease onset may help to further characterize the disease phenotype in psoriatic arthritis.

Alonso S, Tejón P, Sarasqueta C, Coto P, Alperi M, Queiro R.

Joint Bone Spine. 2016 Oct;83(5):533-7. doi: 10.1016/j.jbspin.2015.09.004. Epub 2015 Dec 29.

PMID:
26750761
31.

CDKAL1 gene variants affect the anti-TNF response among Psoriasis patients.

Coto-Segura P, Batalla A, González-Fernández D, Gómez J, Santos-Juanes J, Queiro R, Alonso B, Iglesias S, Coto E.

Int Immunopharmacol. 2015 Dec;29(2):947-949. doi: 10.1016/j.intimp.2015.11.008. Epub 2015 Nov 10.

PMID:
26563541
32.

Association between single nucleotide polymorphisms IL17RA rs4819554 and IL17E rs79877597 and Psoriasis in a Spanish cohort.

Batalla A, Coto E, González-Lara L, González-Fernández D, Gómez J, Aranguren TF, Queiro R, Santos-Juanes J, López-Larrea C, Coto-Segura P.

J Dermatol Sci. 2015 Nov;80(2):111-5. doi: 10.1016/j.jdermsci.2015.06.011. Epub 2015 Jun 27.

PMID:
26347322
33.

HLA-B27 and psoriatic disease: a modern view of an old relationship.

Queiro R, Morante I, Cabezas I, Acasuso B.

Rheumatology (Oxford). 2016 Feb;55(2):221-9. doi: 10.1093/rheumatology/kev296. Epub 2015 Aug 19. Review.

PMID:
26289052
34.

A deletion at ADAMTS9-MAGI1 locus is associated with psoriatic arthritis risk.

Julià A, Pinto JA, Gratacós J, Queiró R, Ferrándiz C, Fonseca E, Montilla C, Torre-Alonso JC, Puig L, Pérez Venegas JJ, Fernández Nebro A, Fernández E, Muñoz-Fernández S, Daudén E, González C, Roig D, Sánchez Carazo JL, Zarco P, Erra A, López Estebaranz JL, Rodríguez J, Ramírez DM, de la Cueva P, Vanaclocha F, Herrera E, Castañeda S, Rubio E, Salvador G, Díaz-Torné C, Blanco R, Willisch Domínguez A, Mosquera JA, Vela P, Tornero J, Sánchez-Fernández S, Corominas H, Ramírez J, López-Lasanta M, Tortosa R, Palau N, Alonso A, García-Montero AC, Gelpí JL, Codó L, Day K, Absher D, Myers RM, Cañete JD, Marsal S.

Ann Rheum Dis. 2015 Oct;74(10):1875-81. doi: 10.1136/annrheumdis-2014-207190. Epub 2015 May 19.

35.

The Cw6 and late-cornified envelope genotype plays a significant role in anti-tumor necrosis factor response among psoriatic patients.

Batalla A, Coto E, González-Fernández D, González-Lara L, Gómez J, Santos-Juanes J, Queiro R, Coto-Segura P.

Pharmacogenet Genomics. 2015 Jun;25(6):313-6. doi: 10.1097/FPC.0000000000000136.

PMID:
25794162
36.

The TNFRSF1B rs1061622 polymorphism (p.M196R) is associated with biological drug outcome in Psoriasis patients.

González-Lara L, Batalla A, Coto E, Gómez J, Eiris N, Santos-Juanes J, Queiro R, Coto-Segura P.

Arch Dermatol Res. 2015 Jul;307(5):405-12. doi: 10.1007/s00403-014-1533-z. Epub 2014 Dec 24.

PMID:
25537528
37.

PDE3A-SLCO1C1 locus is associated with response to anti-tumor necrosis factor therapy in psoriatic arthritis.

Julià A, Rodríguez J, Fernández-Sueiro JL, Gratacós J, Queiró R, Montilla C, Torre-Alonso JC, Pérez-Venegas JJ, Manrique-Arija S, Muñoz-Fernández S, González C, Roig D, Zarco P, Erra A, Castañeda S, García A, Salvador G, Díaz-Torne C, Blanco R, Domínguez AW, Mosquera JA, Vela P, Tornero J, Sánchez-Fernández S, Corominas H, Ramírez J, Avila G, Alonso A, Tortosa R, López-Lasanta M, Cañete JD, Marsal S.

Pharmacogenomics. 2014 Nov;15(14):1763-1769.

PMID:
25493569
38.

Activating killer immunoglobulin-like receptors genes are associated with increased susceptibility to ankylosing spondylitis.

Díaz-Peña R, Vidal-Castiñeira JR, Mulero J, Sánchez A, Queiro R, López-Larrea C.

Clin Exp Immunol. 2015 May;180(2):201-6. doi: 10.1111/cei.12568.

39.

Qualifying unmet needs and improving standards of care in psoriatic arthritis.

Helliwell P, Coates L, Chandran V, Gladman D, de Wit M, FitzGerald O, Kavanaugh A, Strand V, Mease PJ, Boehncke WH, Langley RG, Lubrano E, Maccarone M, Schulze-Koops H, Miceli-Richard C, Queiro R.

Arthritis Care Res (Hoboken). 2014 Dec;66(12):1759-66. doi: 10.1002/acr.22404. Review. No abstract available.

40.

Genetic variation at IL12B, IL23R and IL23A is associated with psoriasis severity, psoriatic arthritis and type 2 diabetes mellitus.

Eirís N, González-Lara L, Santos-Juanes J, Queiro R, Coto E, Coto-Segura P.

J Dermatol Sci. 2014 Sep;75(3):167-72. doi: 10.1016/j.jdermsci.2014.05.010. Epub 2014 Jun 11.

PMID:
24957500
41.

Effect of the FTO rs9930506 polymorphism on obesity and the main clinical outcomes in patients with psoriasis.

Coto-Segura P, González-Lara L, Eiris N, Santos-Juanes J, Queiro R, Coto E.

Br J Dermatol. 2014 Oct;171(4):917-9. doi: 10.1111/bjd.13000. Epub 2014 Aug 5. No abstract available.

PMID:
24673193
42.

Recommendations for the coordinated management of psoriatic arthritis by rheumatologists and dermatologists: a Delphi study.

Cañete JD, Daudén E, Queiro R, Aguilar MD, Sánchez-Carazo JL, Carrascosa JM, Carretero G, García-Vivar ML, Lázaro P, López-Estebaranz JL, Montilla C, Ramírez J, Rodríguez-Moreno J, Puig L.

Actas Dermosifiliogr. 2014 Apr;105(3):216-32. doi: 10.1016/j.adengl.2013.07.003. Epub 2014 Mar 20.

PMID:
24657018
43.

The Region Centromeric to HLA-C Is a Key Region for Understanding the Phenotypic Variability of Psoriatic Arthritis.

Queiro R, Tejón P, Alonso S, Coto P, López-Larrea C, Martínez-Borra J, González S.

ISRN Dermatol. 2014 Jan 30;2014:570178. doi: 10.1155/2014/570178. eCollection 2014.

44.

Standards of care for patients with spondyloarthritis.

Abad MÁ, Ariza RA, Aznar JJ, Batlle E, Beltrán E, de Dios Cañete J, de Miguel E, Escudero A, Fernández-Carballido C, Gratacós J, Loza E, Linares LF, Montilla C, Ramos MM, Mulero J, Queiro R, Raya E, Lozano CR, Moreno JR, Sanz J, Silva-Fernández L, Torre Alonso JC, Zarco P, Fernández-Sueiro JL, Juanola X; 2e study group; Spanish Society of Rheumatology.

Rheumatol Int. 2014 Feb;34(2):165-70. doi: 10.1007/s00296-013-2934-6. Epub 2014 Jan 4. Review.

PMID:
24390635
45.

Age at disease onset: a key factor for understanding psoriatic disease.

Queiro R, Tejón P, Alonso S, Coto P.

Rheumatology (Oxford). 2014 Jul;53(7):1178-85. doi: 10.1093/rheumatology/ket363. Epub 2013 Nov 22. Review.

PMID:
24273020
46.

SNP rs11652075 in the CARD14 gene as a risk factor for psoriasis (PSORS2) in a Spanish cohort.

González-Lara L, Coto-Segura P, Penedo A, Eiris N, Díaz M, Santos-Juanes J, Queiro R, Coto E.

DNA Cell Biol. 2013 Oct;32(10):601-4. doi: 10.1089/dna.2013.2109. Epub 2013 Aug 1.

PMID:
23905699
47.

Clinical differences between men and women with psoriatic arthritis: relevance of the analysis of genes and polymorphisms in the major histocompatibility complex region and of the age at onset of psoriasis.

Queiro R, Tejón P, Coto P, Alonso S, Alperi M, Sarasqueta C, González S, Martínez-Borra J, López-Larrea C, Ballina J.

Clin Dev Immunol. 2013;2013:482691. doi: 10.1155/2013/482691. Epub 2013 Apr 16.

48.

Could the clinical differences between men and women with psoriatic arthritis be explained in part by genetic factors?

Queiro R, Tejón P, Coto P, Alperi M, Alonso S, Sarasqueta C, González S, Martínez-Borra J, López-Larrea C, Ballina J.

Clin Exp Rheumatol. 2013 Mar-Apr;31(2):324-5. Epub 2013 Feb 15. No abstract available.

PMID:
23414960
49.

Dropped head syndrome in a patient with scleromyositis.

Fernández-Serna M, Arboleya L, Alonso S, Queiro R, Alperi M.

J Clin Rheumatol. 2013 Jan;19(1):32-4. doi: 10.1097/RHU.0b013e31827d8778. Review.

PMID:
23319021
50.

Erosive discovertebral lesion (Andersson lesion) as the first sign of disease in axial psoriatic arthritis.

Queiro R, Tejón P, Alonso S, Alperi M, Ballina J.

Scand J Rheumatol. 2013;42(3):220-5. doi: 10.3109/03009742.2012.739637. Epub 2013 Jan 14.

PMID:
23311864

Supplemental Content

Loading ...
Support Center